Tobias Meischl

机构：Gesundheitszentrum Oberndorf, Hanusch Hospital, Medical University of Vienna · ORCID：0000-0002-1716-9166

发表论文 46 篇 · 总被引 588 次 · h-index 10

代表论文

• Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline—A Multinational Registry Analysis (2023 · American Journal of Respiratory and Critical Care Medicine · 被引 52)
• The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry (2023 · Respiratory Research · 被引 20)
• Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion (2024 · Cancer Imaging · 被引 9)
• Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients (2023 · PLoS ONE · 被引 9)
• Anaemia is independently associated with mortality in patients with hepatocellular carcinoma (2024 · ESMO Open · 被引 7)
• Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma (2024 · United European Gastroenterology Journal · 被引 6)